We are live on ! Find out more
NRXPW

NRX Pharmaceuticals Warrant
NRXPW

Delisted

NRXPW was delisted on the 22nd of May, 2026.

Back to rankings

13 hedge funds and large institutions have $904K invested in NRX Pharmaceuticals Warrant in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more capital invested

Capital invested by funds: $458K → $904K (+$446K)

24% less funds holding

Funds holding: 17 → 13 (-4)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
13
Holders Change
-4
Holders Change %
-23.53%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
5
Calls
$125K
Puts
–
Net Calls
+$125K
Net Calls Change
+$111K

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$1.96K

Top Sellers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
-$5K
2
CAC
Cowen and Company
New York
-$4K
3
BI
Bulldog Investors
New Jersey
-$3K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1K
5
RCM
Rivernorth Capital Management
Florida
-$201
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$359K – – –
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$165K – – –
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$84K – – –
VAS
4
VR Advisory Services
Cayman Islands
$72K – – –
RCM
5
Rivernorth Capital Management
Florida
$53K -$201 -1,337 -1%
AA
6
AQR Arbitrage
Connecticut
$45K – – –
6CM
7
683 Capital Management
New York
$37K – – –
YCM
8
Yakira Capital Management
Connecticut
$37K – – –
GCL
9
Glazer Capital LLC
New York
$30K – – –
Walleye Trading
10
Walleye Trading
New York
$9K – – –
LIM
11
Longfellow Investment Management
Massachusetts
$5K – – –
HF
12
HRT Financial
New York
$5K +$1.96K +12,979 New
HIM
13
HGC Investment Management
Ontario, Canada
$3K – – –
PC
14
Periscope Capital
Ontario, Canada
– -$5K -91,916 Closed
CAC
15
Cowen and Company
New York
– -$4K -58,686 Closed
BI
16
Bulldog Investors
New Jersey
– -$3K -53,793 Closed
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
– -$1K -21,017 Closed

NRXPW Hedge Fund Activity: Q2 2020 in Review

13 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q2 2020, worth a combined $904K — up 97% from $458K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of NRXPW and 1 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was HRT Financial, opening a new position worth an estimated $1.96K. The largest seller was Periscope Capital, exiting entirely with an estimated $5K sold.

  • 13 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q2 2020, down from 17 in Q1 2020.
  • Funds reported $904K of NRX Pharmaceuticals Warrant stock for Q2 2020, up 97% quarter-over-quarter.
  • 1 fund opened new NRX Pharmaceuticals Warrant positions in Q2 2020 and 5 closed out, a net change of -4 holders.
  • The largest NRX Pharmaceuticals Warrant buyer in Q2 2020 was HRT Financial, an estimated $1.96K added.
  • The largest NRX Pharmaceuticals Warrant seller in Q2 2020 was Periscope Capital, an estimated $5K sold.

Based on aggregated 13F filings for Q2 2020.